Editorial Board |
|
iii | |
Contributors |
|
v | |
Preface: New Directions for the Journal's Second Year |
|
xi | |
|
|
|
|
Multifactorial Rehabilitation Planning in Companion Animals |
|
|
|
Denis J. Marcellin-Little |
|
|
|
|
|
1 | (1) |
|
General features of rehabilitation programs |
|
|
1 | (2) |
|
Musculoskeletal tissue atrophy resulting from disuse |
|
|
3 | (1) |
|
Selecting management options during physical rehabilitation |
|
|
4 | (1) |
|
Proactive and retroactive forms of physical rehabilitation |
|
|
4 | (1) |
|
Logistics of Physical Rehabilitation |
|
|
5 | (1) |
|
|
5 | (3) |
|
|
8 | (1) |
|
|
9 | (1) |
|
|
9 | (1) |
|
|
9 | (1) |
|
|
10 | (1) |
|
Cryotherapy in Small Animal Rehabilitation |
|
|
|
|
Denis J. Marcellin-Little |
|
|
|
11 | (1) |
|
Physiologic effects of cryotherapy |
|
|
11 | (1) |
|
Influences of cryotherapy on other rehabilitation treatments |
|
|
12 | (1) |
|
Application, risks, and precautions |
|
|
12 | (1) |
|
Types of cryotherapy devices |
|
|
12 | (1) |
|
|
13 | (2) |
|
Cryotherapy over coaptation devices |
|
|
15 | (1) |
|
|
16 | (1) |
|
|
16 | (3) |
|
Manual Therapy in Small Animal Rehabilitation |
|
|
|
|
|
|
|
|
19 | (1) |
|
|
19 | (1) |
|
|
20 | (1) |
|
Contraindications and precautions to soft-tissue mobilization |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
22 | (1) |
|
|
22 | (1) |
|
Passive, active range of motion and stretching |
|
|
22 | (1) |
|
Additional manual techniques |
|
|
22 | (1) |
|
|
23 | (1) |
|
|
23 | (1) |
|
Review of joint mobilizations |
|
|
23 | (3) |
|
|
24 | (2) |
|
|
26 | (1) |
|
|
26 | (1) |
|
|
26 | (5) |
|
The Role of Strengthening in the Management of Canine Osteoarthritis: A Review |
|
|
|
|
|
|
Denis J. Marcellin-Little |
|
|
|
31 | (2) |
|
Strength training and aerobic activity in osteoarthritis |
|
|
33 | (1) |
|
Resistance training in osteoarthritis |
|
|
34 | (1) |
|
|
35 | (2) |
|
Principles of Aquatic Therapy |
|
|
36 | (1) |
|
|
37 | (1) |
|
|
37 | (1) |
|
|
37 | (2) |
|
Emergency and Critical Care Crystalloids versus Colloids: Same Controversy, New Information |
|
|
|
|
|
39 | (1) |
|
|
39 | (6) |
|
|
40 | (1) |
|
|
40 | (1) |
|
Normal Saline Versus Balanced Electrolyte Solutions |
|
|
41 | (1) |
|
Acute Kidney Injury and Colloids |
|
|
42 | (1) |
|
Coagulopathies and Colloids |
|
|
43 | (1) |
|
|
44 | (1) |
|
Present relevance and future avenues to consider or to investigate |
|
|
45 | (1) |
|
|
45 | (1) |
|
|
45 | (4) |
|
Current and Future Practice in the Diagnosis and Management of Sepsis and Septic Shock in Small Animals |
|
|
|
|
|
49 | (2) |
|
Significance (in depth analysis) |
|
|
51 | (2) |
|
Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock |
|
|
51 | (2) |
|
Present relevance and future avenues to consider or to investigate |
|
|
53 | (1) |
|
|
54 | (9) |
|
|
54 | (2) |
|
|
56 | (7) |
|
|
63 | (1) |
|
|
64 | (6) |
|
Current Standards and Practices in Small Animal Mechanical Ventilation |
|
|
|
|
Initiating mechanical ventilation |
|
|
70 | (1) |
|
|
71 | (1) |
|
Application of positive end-expiratory pressure |
|
|
72 | (1) |
|
Suggested initial settings |
|
|
72 | (1) |
|
Monitoring the mechanically ventilated patient |
|
|
72 | (7) |
|
Equipment Care and Safety Checks |
|
|
73 | (1) |
|
|
73 | (6) |
|
Complications of mechanical ventilation |
|
|
79 | (1) |
|
Weaning from mechanical ventilation |
|
|
79 | (3) |
|
Recovery from mechanical ventilation |
|
|
82 | (1) |
|
|
82 | (3) |
|
Medical and Surgical Management of Ureteral Obstructions |
|
|
|
|
|
85 | (1) |
|
|
85 | (1) |
|
|
86 | (1) |
|
|
87 | (1) |
|
|
88 | (1) |
|
Interventional management |
|
|
89 | (7) |
|
|
96 | (1) |
|
Ureteral intervention decision-making |
|
|
96 | (1) |
|
|
97 | (1) |
|
|
97 | (4) |
|
|
|
Current Knowledge on Canine Atopic Dermatitis: Pathogenesis and Treatment |
|
|
|
|
|
|
101 | (1) |
|
|
102 | (4) |
|
|
103 | (1) |
|
|
103 | (2) |
|
Epidermal Barrier Dysfunction |
|
|
105 | (1) |
|
|
105 | (1) |
|
Dysbiosis of the Cutaneous Microbiome |
|
|
106 | (1) |
|
|
106 | (5) |
|
The Role of Topical Therapies |
|
|
107 | (2) |
|
Systemic Anti-inflammatory and Antipruritic Therapies |
|
|
109 | (2) |
|
Allergen-Specific Immunotherapy |
|
|
111 | (1) |
|
|
111 | (1) |
|
Future avenues to consider |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
|
Reevaluation of Prescription Strategies for Intermittent and Prolonged Renal Replacement Therapies |
|
|
|
|
|
|
111 | (8) |
|
Current intermittent hemodialysis and intermittent hemodialysis hybrid prescription and delivery assessments |
|
|
119 | (1) |
|
A reassessed paradigm for dialysis prescription and delivery |
|
|
120 | (2) |
|
Therapeutic and prescription presumptions |
|
|
122 | (3) |
|
Reprised urea reduction ratio approach and prolonged intermittent renal replacement therapy calculator to deliver renal replacement by fractional urea clearance |
|
|
125 | (2) |
|
Prolonged Intermittent Renal Replacement Therapy with Hemofiltration |
|
|
127 | (1) |
|
Prolonged Intermittent Renal Replacement Therapy with Hemodialysis |
|
|
127 | (1) |
|
Prolonged Intermittent Renal Replacement Therapy with Hemodiafiltration |
|
|
127 | (1) |
|
|
127 | (1) |
|
|
127 | (4) |
|
Activated Carbon Hemoperfusion and Plasma Adsorption: Rediscovery and Veterinary Applications of These Abandoned Therapies |
|
|
|
|
|
|
|
131 | (1) |
|
|
131 | (2) |
|
|
133 | (1) |
|
|
133 | (2) |
|
Legacy and modern sorbents |
|
|
135 | (1) |
|
Use of hemoperfusion in drug overdose and poisoning |
|
|
136 | (1) |
|
Volume of Distribution and Water Solubility |
|
|
136 | (1) |
|
Hemoperfusion in other disease conditions |
|
|
137 | (2) |
|
Hemoperfusion; therapy delivery |
|
|
139 | (1) |
|
Hemoperfusion; complications |
|
|
139 | (2) |
|
|
141 | (1) |
|
|
141 | (1) |
|
|
142 | (1) |
|
|
142 | (1) |
|
Vaccine-Enhanced Adoptive T-Cell Therapy to Treat Canine Cancers |
|
|
|
|
|
|
143 | (1) |
|
General overview, background, and study rationale for vaccine-enhanced adoptive cell therapy |
|
|
144 | (3) |
|
Vaccine-enhanced adoptive cell therapy in dogs: protocol and components |
|
|
147 | (5) |
|
Individual Vaccine-Enhanced Adoptive Cell Therapy Components and Sequence |
|
|
147 | (3) |
|
Vaccine-Enhanced Adoptive Cell Therapy Use in Canine Osteosarcoma |
|
|
150 | (2) |
|
Significance and future directions |
|
|
152 | (1) |
|
|
153 | (4) |
|
|
|
How to Toughen Them up Without Roughin' Them Up |
|
|
|
|
|
|
157 | (1) |
|
|
158 | (1) |
|
Ways to teach the skill set without roughing up the students |
|
|
158 | (1) |
|
|
159 | (1) |
|
|
159 | (1) |
|
|
160 | (1) |
|
|
160 | (1) |
|
Awareness of life experiences |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
162 | (1) |
|
|
162 | (1) |
|
|
162 | (1) |
|
The Myth of Compassion Fatigue and the Reality of Emotional Fatigue |
|
|
|
|
|
163 | (1) |
|
Compassion fatigue versus emotional fatigue |
|
|
164 | (1) |
|
Emotional fatigue in veterinary medicine |
|
|
165 | (3) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
167 | (1) |
|
High Debt-to-income Ratio |
|
|
167 | (1) |
|
Euthanasia-Related Stress |
|
|
168 | (1) |
|
Separating emotional fatigue from compassion fatigue |
|
|
168 | (1) |
|
Combating emotional fatigue |
|
|
169 | (2) |
|
Remaining in Service to People and Pets |
|
|
169 | (1) |
|
|
170 | (1) |
|
Reframing Conversations about Compassion Fatigue |
|
|
171 | (1) |
|
|
171 | (1) |
|
|
171 | |